Already at best price
Mosi-DF Eye Drop
Difluprednate (0.5mg) + Moxifloxacin (5mg)
FDC Ltd
Eye Infection
₹99.00
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
₹99.00
Active composition
Difluprednate 0.5 mg
+1 more active ingredient
How It Works
Difluprednate inhibits the production of pro-inflammatory cytokines, reducing inflammation and pain in the eye.
Moxifloxacin inhibits DNA gyrase and topoisomerase IV, disrupting bacterial DNA replication and transcription.
Medicine Strength
0.5 mg
All Active Ingredients
Difluprednate0.5 mg
Moxifloxacin5 mg
Uses & Benefits
Medical applications
PainInflammationBacterialFlu
Mosi-DF Eye Drop is a topical corticosteroid and antiproliferative agent combination product indicated for the treatment of inflammation and pain associated with cataract surgery and inflammatory postoperative ocular wounds. The product contains a fixed combination of moxifloxacin 5mg and difluprednate 0.5mg per 0.1mL. Moxifloxacin, a fluoroquinolone antibacterial agent, inhibits bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial DNA replication and transcription. Difluprednate, a corticosteroid, reduces inflammation and pain by inhibiting the release of inflammatory mediators and suppressing the immune response. The combination of these two agents provides a synergistic effect in reducing inflammation and pain, making Mosi-DF Eye Drop a valuable adjunct to surgery in patients undergoing cataract surgery or treated for inflammatory postoperative ocular wounds. The product is administered topically, three times a day, and may be used for up to 28 days.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
✓Only 2.3% reported effects
Common Side Effects
Headache8%
Nausea5%
Higher
Lower
Safety Advice
Alcohol
Information regarding the use of Mosi-DF Eye Drop during pregnancy is not available. Please consult your doctor.
High Risk
Pregnancy
Mosi-DF Eye Drop should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Medical Advice
Driving
No interaction found/established
Exercise Caution
Breastfeeding
Mosi-DF Eye Drop may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Consult Doctor
Kidney
No interaction found/established
Regular Checkup
Customer Reviews
0 reviews for Mosi-DF Eye Drop
Mosi-DF Eye Drop
1 / 2
Rx RequiredSchedule H
Mosi-DF Eye Drop
Moxifloxacin (5mg) + Difluprednate (0.5mg)
₹99.00
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
Cheaper alternative availability
Not Foundfor this medicine
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Difluprednate 0.5 mg
+1 more active ingredient
How It Works
Difluprednate inhibits the production of pro-inflammatory cytokines, reducing inflammation and pain in the eye.
Moxifloxacin inhibits DNA gyrase and topoisomerase IV, disrupting bacterial DNA replication and transcription.
Medicine Strength
0.5 mg
All Active Ingredients
Difluprednate0.5 mg
Moxifloxacin5 mg
Uses & Benefits
Medical applications
PainInflammationBacterialFlu
Mosi-DF Eye Drop is a topical corticosteroid and antiproliferative agent combination product indicated for the treatment of inflammation and pain associated with cataract surgery and inflammatory postoperative ocular wounds. The product contains a fixed combination of moxifloxacin 5mg and difluprednate 0.5mg per 0.1mL. Moxifloxacin, a fluoroquinolone antibacterial agent, inhibits bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial DNA replication and transcription. Difluprednate, a corticosteroid, reduces inflammation and pain by inhibiting the release of inflammatory mediators and suppressing the immune response. The combination of these two agents provides a synergistic effect in reducing inflammation and pain, making Mosi-DF Eye Drop a valuable adjunct to surgery in patients undergoing cataract surgery or treated for inflammatory postoperative ocular wounds. The product is administered topically, three times a day, and may be used for up to 28 days.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
✓Only 2.3% reported effects
Common Side Effects
Headache8%
Nausea5%
Higher
Lower
Safety Advice
Alcohol
Information regarding the use of Mosi-DF Eye Drop during pregnancy is not available. Please consult your doctor.
High Risk
Pregnancy
Mosi-DF Eye Drop should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Medical Advice
Driving
No interaction found/established
Exercise Caution
Breastfeeding
Mosi-DF Eye Drop may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Consult Doctor
Kidney
No interaction found/established
Regular Checkup
Customer Reviews
0 reviews for Mosi-DF Eye Drop
